Benchmarking Integrated Care for People Living With Huntington's Disease in England

NCT ID: NCT05828992

Last Updated: 2023-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-28

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey and full study information can be accessed here: https://southampton.qualtrics.com/jfe/form/SV\_8iEedDJZy4xaiI6

The goal of this anonymous survey is to benchmark integrated care from the perspective of service users in adults living with Huntington's Disease, including informal caregivers. The main question it aims to answer is: Is standard of care for people living with HD in England person-centred integrated care from the perspective of service users?

Participants will complete a one-time anonymous survey either online or on paper, according to their preference, that takes an average of 20-30 minutes. Participants can take breaks as needed, picking up the survey from where it was paused.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Huntington's disease (HD) is a rare brain disease that affects people's coordination, thinking and behaviour. It is a hereditary condition, affecting families across generations. Because its complex, it requires different sectors working together. Different surveys can be found in long term neurological conditions indicating care fragmentation and unmet severe needs, but evidence in HD is sparse.

Two surveys were identified covering people's needs in the UK, dated from 2006 and 2010. When looking for models or approaches tested to improve outcomes for people living with HD, no studies were found. This is an underserved population with complex needs and care gaps that remain unaddressed.

Little is known about to what extent people living with HD are experiencing care coordination between services and sectors in England. Integrate-HD aims to find out what good, joined-up care looks like. The study will explore the views and experiences of people living with HD, to identify the changes needed to improve people's care and quality of life.

Integrate-HD is a national survey to benchmark integrated care from the perspective of people living with HD, including informal caregivers.

The study objectives are to:

1. Characterise and classify systems/organisations in England involved in HD care in relation to person-centred integrated care from the perspective of users.
2. Identify areas considered integrated by service users.
3. Identify areas considered fragmented by service users.
4. Map care resources used by people living with HD in England.
5. Identify unmet care needs that need improvement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Huntington Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Person at risk

Survey personalised for people living at risk of developing Huntington's Disease, meaning they have a parent diagnosed with HD but the person themselves have not undertaken a genetic test.

No intervention administered

Intervention Type OTHER

Survey only to gather people's experiences, opinions and needs.

Person HD gene positive asymptomatic

Survey personalised for people that tested positive in their predictive genetic test but have not been yet diagnosed with clinical HD (manifest HD).

No intervention administered

Intervention Type OTHER

Survey only to gather people's experiences, opinions and needs.

Person HD gene positive symptomatic

Survey personalised for people that tested positive in their predictive genetic test and have been diagnosed with clinical HD (manifest HD).

No intervention administered

Intervention Type OTHER

Survey only to gather people's experiences, opinions and needs.

Informal caregiver

Survey personalised for people caring for another person diagnosed with HD.

No intervention administered

Intervention Type OTHER

Survey only to gather people's experiences, opinions and needs.

Former informal caregiver

Survey personalised for people that have cared for another person diagnosed with HD in the last 3 years.

No intervention administered

Intervention Type OTHER

Survey only to gather people's experiences, opinions and needs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention administered

Survey only to gather people's experiences, opinions and needs.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adults with capacity living in England and fluent in English that are:

* A person at risk of HD (where at least one parent is diagnosed with HD, therefore their offspring has 50% chance of developing the disease);
* A person diagnosed with HD symptomatic or asymptomatic (after undergoing gene testing and having a positive result);
* An informal caregiver supporting someone living with HD;
* A former informal caregiver with experience of supporting someone living with HD in the last 3 years.

Exclusion Criteria

* Below 18 years old;
* Not fluent in English;
* A person without capacity.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute for Health Research, United Kingdom

OTHER_GOV

Sponsor Role collaborator

Central Coast Research Institute for Integrated Care, Australia

UNKNOWN

Sponsor Role collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

Sponsor Role collaborator

University of Southampton

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sandra B Pires, MSc

Role: PRINCIPAL_INVESTIGATOR

University of Southampton

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Southampton

Southampton, Hampshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sandra B Pires, MSc

Role: CONTACT

07873576074

Mari Carmen Portillo, Professor

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sandra B Pires, MSc

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ERGO number: 77725

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Maximizing Independence at Home (MIND at Home)
NCT01283750 COMPLETED PHASE2/PHASE3